Construction milestone celebrated at new King’s Cross science facility

A topping out ceremony has been held at Versa, a new purpose-built laboratory facility at King’s Cross, to mark a key moment in the project’s construction.

Morgan Sindall Construction’s London business was appointed to deliver the project by Kadans Science Partner (“Kadans”), a leading European investor in the development of ecosystems and real estate with a dedicated focus on knowledge-intensive sectors.

This is the second facility to be delivered by Kadans within the Tileyard Quarter in King’s Cross, London, and when complete will provide a significant boost to London’s life science sector.

Representatives from Kadans, Morgan Sindall, cost consultants CB3, PSK Building Surveyors, David Miller Architects, structural engineering firm HDR, and services engineers HoareLea attended the event in late September. During the ceremony Will Fogden, Head of Investment and Development at Kadans. delivered a speech to celebrate this significant milestone.

Due to complete in Q2 2026 and located at 4 Brandon Road, Versa will provide 51,500 sq. ft of space, designed to accommodate a variety of uses from CL2 labs to production and pilot spaces, supplying key King’s Cross specialisms including biomedical, life science, data, and precision medicine with cutting-edge facilities tailored to the needs of pioneering companies and individuals.

The four-storey building will also include best-in-class amenities, such as dedicated cycle parking, on-site showers and private, landscaped external space for occupiers to enjoy, improving wellbeing, productivity, and knowledge sharing.

This project follows last year’s completion of the neighbouring 114,000 sq. ft Mayde building in the Tileyard Quarter. This hub of high specification lab and office spaces, which was developed by Kadans and constructed by Morgan Sindall, has become a central part of London’s life science cluster.

Versa will supplement the existing facilities at Mayde, where tenants can access high quality GMP and pilot manufacturing facilities, fully operated CAT B spaces and CAT A labs complemented by associated write up, specifically designed to support expansion from research and development into commercialisation. The combination of these two buildings sets an exciting platform for Kadans’ further development plans to deliver over 300,000 sq. ft of high specification laboratory, office, and manufacturing space at Tileyard Quarter.

Occupiers of these spaces will be part of a close-knit community of academics, creatives, independent businesses, and clinicians across King’s Cross while also benefiting from access to Kadans’ global support network of occupiers and partners as well as those situated within the Tileyard Quarter.